Transcranial Magnetic Stimulator Market Size, Share & Trends Analysis Report By Type (dTMS, rTMS, Others), By Application (Depression, Epilepsy); By Region (U.S., Canada, Mexico, Rest of North America, UK, France, Germany, Italy, Spain, Benelux Union, Nordic Countries , Rest of Europe, China, Japan, India, South Korea, Singapore, Philippines, Indonesia, Thailand, Malaysia, Vietnam, Rest of Southeast Asia, Brazil, Argentina Rest of Latin America, Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2019 - 2027
Industry Trends
Global transcranial magnetic stimulator market was valued at US$ 736.01 million in 2018 and is expected to reach US$ 1363.69 million by 2027, growing at an estimated CAGR of 7.1% over the forecast period. Transcranial magnetic stimulation (TMS) is a non-invasive brain stimulation technique that uses magnetic induction forces to concentrate on a specific brain region. The electromagnetic induction is produced by electricity from a coil and these pulses pass through the cranium to the brain's designated receptor region. There are several different brain stimulation methods available including electroconvulsive therapy and deep brain stimulation techniques; however, the most widely adopted approach for brain stimulation is actually the transcranial magnetic stimulation technique. TMS-instigated decrease of cortical volatility has potential clinical applications in illnesses, for example, epilepsy and myoclonus. Spread of excitation, which might be an admonition sign for seizures, happened in one subject and was not joined by expanded MEP sufficiency, proposing that spread of excitation and plentifulness changes are various marvels and furthermore showing the requirement for sufficient checking even with incitements at low frequencies.
Promoting both existing treatment options and greater access to treatment may be more clinically significant than the development of entirely new treatment modalities, because many individuals who face depression receive no treatment for their symptoms. Many alternative treatments for patients with major depressive disorder (MDD) have emerged in recent years. Among these, repetitive transcranial magnetic stimulation (rTMS), a promising neuromodulatory technique, has been demonstrated to be safe and effective for the treatment for MDD. Previous studies have demonstrated the antidepressant efficacy of high-frequency rTMS when applied to the left dorsolateral prefrontal cortex (DLPFC). Treatment with rTMS is portrayed by numerous factors including incitement force, recurrence, the quantity of trains and their interims, and the site of utilization. The significance of these factors with the impacts of rTMS on gloom stay hazy. Past investigations have proposed that suprathreshold rTMS incitement is better than subthreshold rTMS incitement for the treatment of wretchedness.
Central point expected to drive the Transcranial Magnetic Stimulator Market during the estimate time frame are expanded predominance of neurological issue including schizophrenia and different issue, expanded geriatric populace prompting increased age-related brain disorders, increasing use of transcranial magnetic stimulation techniques in diagnosis and neurological treatment. Nonetheless, clinically proven high efficiency of electroconvulsive therapy in treating psychotic depression and increasing numbers of patients taking the therapy are likely to be one of the major constraints on the demand for transcranial magnetic stimulators during the forecast period.
Type Insights
Due to the increasing prevalence of Major Depressive Disorder (MDD) & other mental disorders and increasing awareness, Deep TMS (dTMS) segment is expected to dominate the Transcranial Magnetic Stimulator Market in the projected time period. Deep TMS is a technique that uses a coil mounted on the scalp to produce magnetic fields. It also allows non-invasive care for those with neurological disorders such as depression in deep brain regions. Repetitive TMS (rTMS) is expected to be the fastest growing segment as proposed as the novel treatment for depression and anxiety that allows direct stimulation of deeper and greater volumes of brain (7-10). It is a non-invasive type of brain stimulation and involves neither surgery nor electrode implantation. Research has found that rTMS can be used to treat many psychiatric disorders, including unipolar depression, schizophrenia, and bipolar disorder.
Transcranial magnetic stimulation (TMS) is one of a few rising medicines that can possibly offer people a safe and non-intrusive option in contrast to epilepsy medical procedure. Since a long time ago utilized as an exploration device to examine mind work, TMS has likewise been considered as a potential treatment for various neurological conditions, including epilepsy. This non-careful and easy treatment utilizes incited attractive flows to balance mind work so as to lessen the propensity to have seizures. A portion of the preliminaries show that TMS lessens the quantity of seizures people had contrasted with before the treatment, however different preliminaries didn't show any huge contrasts in seizure recurrence. Four preliminaries demonstrated a decrease in epileptiform releases following TMS treatment. The incitement parameter space additionally incorporates singular boost segments, for example, beat shape (rectangular, sinusoidal, exponential) and plentifulness. The physiologic reaction to TMS is additionally dictated by boost train parameters, for example, recurrence, span, between train interim, and the quantity of trains per unit time. The electric field generated by TMS is not measured in vivo but can be effectively modelled and represented in volts per meter (V/m). Alternatively, TMS-induced current density can be approximated in ampere per square meter.
Contrasted with regular monophasic and biphasic TMS, cTMS lessens vitality dissemination by 78-82% and 55-57% and diminishes curl warming by 15-33% and 31-41%, individually. We exhibit dreary TMS (rTMS) trains of 3,000 heartbeats at frequencies up to 50 Hz with E-field heartbeat sufficiency and width inconstancy of under 1.7% and 1%, separately. The diminished force utilization and curl warming, and the adaptable heartbeat parameter alteration offered by cTMS could improve existing TMS ideal models and could empower novel research and clinical applications with potentially enhanced potency.
Application Insights
Significant misery is frequently hard to analyse precisely. In any event, when the analysis is appropriately made, standard treatment draws near (e.g., psychotherapy, drugs, or their mix) are regularly lacking to control intense side effects or keep up starting advantage. Extra obstructions include wellbeing and bearableness issues, which every now and again block a satisfactory course of treatment. This leaves a significant hole in our capacity to appropriately oversee significant despondency in a generous extent of patients, leaving them defenceless against following entanglements (e.g., work related inability, expanded danger of suicide, comorbid clinical scatters, and substance misuse). Consequently, there is a requirement for progressively viable and better endured approaches. Transcranial attractive incitement is a neuromodulator method progressively used to incompletely fill this restorative void. TMS is interesting among the neurostimulation advancements that have been applied in epilepsy in its ability as either an indicative or a helpful apparatus. Especially, navigated TMS (nTMS), where the TMS administrator efficiently actuates various cerebrum areas to distinguish an engine or language reaction, has become a significant piece of epilepsy medical procedure assessment in some clinical focuses. nTMS supplements fMRI and Wada as a guide to the epilepsy medical procedure plan and as a way to gauge the danger of useful shortage after epilepsy medical procedure.
Region Insights
Because of good repayment approaches, high information, the accessibility of profoundly talented doctors and the nearness of settled human services offices in the zone, North America is required to rule the transcranial attractive triggers showcase. In any case, developing acknowledgment of mechanically propelled items and expanding government support for R&D in gadgets and surgeries for advancements are driving further development. Asia Pacific is anticipated to see the most elevated development rate over the figure time frame because of the expanding commonness of physiological and neurological issue, expanded government activities and an expanding number of NGO-drove mindfulness programs. Expanding clinical the travel industry in the district's developing economies, rising MDD frequency and developing social insurance spending additionally drive the Transcranial Magnetic Stimulator Market.
With an expected 1.9 million individuals, or 4.1% of the total population, experiencing burdensome scatters, South Korea speaks to a broad undiscovered market open door for BrainsWay. With Healthcare's profound industry connections in South Korea will help extend our business impression for Deep TMS in Asia. We keep on concentrating on expanding BrainsWay's universal reach by means of new merchants and operators
Transcranial Magnetic Stimulator Market Revenue & Forecast, (US$ Million), 2015 – 2027
Competitive Landscape
The report provides both, qualitative and quantitative research of transcranial magnetic stimulator market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
The primary Transcranial Magnetic Stimulator Market participants include Brainsway Ltd.; Nexstim Plc; Magstim; Neuronetics, Inc.; TMS Neurosolutions; Mag Venture; and eNeura Inc amongst others. These players concentrate on introducing new technology and strategies for expansion, such as mergers & acquisitions.
Transcranial Magnetic Stimulator Market:
- By Type
- dTMS
- rTMS
- Others
- By Application
- Depression
- Epilepsy
- By Geography
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
- North America
Table of Contents
1. Market Scope
1.1. Market
Segmentation
1.2. Years
Considered
1.2.1. Historic
Years: 2015 - 2017
1.2.2. Base
Year: 2018
1.2.3. Forecast
Years: 2019 – 2027
2. Key Target Audiences
3. Research Methodology
3.1. Primary
Research
3.1.1. Research
Questionnaire
3.1.2. Global
Percentage Breakdown
3.1.3. Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary
Research
3.2.1. Paid
Databases
3.2.2. Secondary
Sources
3.3. Market
Size Estimates
3.3.1. Top-Down
Approach
3.3.2. Bottom-Up
Approach
3.4. Data
Triangulation Methodology
3.5. Research
Assumptions
4. Recommendations and Insights from AMI’s Perspective**
5. Holistic Overview of Transcranial Magnetic Stimulator Market
6. Market Synopsis:
Transcranial Magnetic Stimulator Market
7. Transcranial Magnetic Stimulator Market Analysis: Qualitative
Perspective
7.1. Introduction
7.1.1. Product
Definition
7.1.2. Industry
Development
7.2. Market
Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.3. Trends in
Transcranial Magnetic Stimulator Market
7.4. Market
Determinants Radar Chart
7.5. Macro-Economic
and Micro-Economic Indicators: Transcranial Magnetic Stimulator Market
7.6. Porter’s
Five Force Analysis
8. Global Transcranial Magnetic Stimulator Market Analysis and
Forecasts, 2019 – 2027
8.1. Overview
8.1.1. Global
Transcranial Magnetic Stimulator Market Revenue (US$ Mn)
8.2. Global
Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Type
8.2.1. Deep TMS
8.2.1.1. Definition
8.2.1.2. Market
Estimation and Penetration, 2015 – 2018
8.2.1.3. Market
Forecast, 2019 – 2027
8.2.1.4. Compound
Annual Growth Rate (CAGR)
8.2.1.5. Regional
Bifurcation
8.2.1.5.1. North
America
8.2.1.5.1.1. Market
Estimation, 2015 – 2018
8.2.1.5.1.2. Market
Forecast, 2019 – 2027
8.2.1.5.2. Europe
8.2.1.5.2.1. Market
Estimation, 2015 – 2018
8.2.1.5.2.2. Market
Forecast, 2019 – 2027
8.2.1.5.3. Asia
Pacific
8.2.1.5.3.1. Market
Estimation, 2015 – 2018
8.2.1.5.3.2. Market
Forecast, 2019 – 2027
8.2.1.5.4. Middle
East and Africa
8.2.1.5.4.1. Market
Estimation, 2015 – 2018
8.2.1.5.4.2. Market
Forecast, 2019 – 2027
8.2.1.5.5. Latin
America
8.2.1.5.5.1. Market
Estimation, 2015 – 2018
8.2.1.5.5.2. Market
Forecast, 2019 – 2027
8.2.2. Repetitive
TMS
8.2.2.1. Definition
8.2.2.2. Market
Estimation and Penetration, 2015 – 2018
8.2.2.3. Market
Forecast, 2019 – 2027
8.2.2.4. Compound
Annual Growth Rate (CAGR)
8.2.2.5. Regional
Bifurcation
8.2.2.5.1. North
America
8.2.2.5.1.1. Market
Estimation, 2015 – 2018
8.2.2.5.1.2. Market
Forecast, 2019 – 2027
8.2.2.5.2. Europe
8.2.2.5.2.1. Market
Estimation, 2015 – 2018
8.2.2.5.2.2. Market
Forecast, 2019 – 2027
8.2.2.5.3. Asia
Pacific
8.2.2.5.3.1. Market
Estimation, 2015 – 2018
8.2.2.5.3.2. Market
Forecast, 2019 – 2027
8.2.2.5.4. Middle
East and Africa
8.2.2.5.4.1. Market
Estimation, 2015 – 2018
8.2.2.5.4.2. Market
Forecast, 2019 – 2027
8.2.2.5.5. Latin
America
8.2.2.5.5.1. Market
Estimation, 2015 – 2018
8.2.2.5.5.2. Market
Forecast, 2019 – 2027
8.2.3. Others
8.2.3.1. Definition
8.2.3.2. Market
Estimation and Penetration, 2015 – 2018
8.2.3.3. Market
Forecast, 2019 – 2027
8.2.3.4. Compound
Annual Growth Rate (CAGR)
8.2.3.5. Regional
Bifurcation
8.2.3.5.1. North
America
8.2.3.5.1.1. Market
Estimation, 2015 – 2018
8.2.3.5.1.2. Market
Forecast, 2019 – 2027
8.2.3.5.2. Europe
8.2.3.5.2.1. Market
Estimation, 2015 – 2018
8.2.3.5.2.2. Market
Forecast, 2019 – 2027
8.2.3.5.3. Asia
Pacific
8.2.3.5.3.1. Market
Estimation, 2015 – 2018
8.2.3.5.3.2. Market
Forecast, 2019 – 2027
8.2.3.5.4. Middle
East and Africa
8.2.3.5.4.1. Market
Estimation, 2015 – 2018
8.2.3.5.4.2. Market
Forecast, 2019 – 2027
8.2.3.5.5. Latin
America
8.2.3.5.5.1. Market
Estimation, 2015 – 2018
8.2.3.5.5.2. Market
Forecast, 2019 – 2027
8.3. Key
Segment for Channeling Investments
8.3.1. By Type
9. Global Transcranial Magnetic Stimulator Market Analysis and
Forecasts, 2019 – 2027
9.1. Overview
9.2. Global
Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By
Application
9.2.1. Depression
9.2.1.1. Definition
9.2.1.2. Market
Estimation and Penetration, 2015 – 2018
9.2.1.3. Market
Forecast, 2019 – 2027
9.2.1.4. Compound
Annual Growth Rate (CAGR)
9.2.1.5. Regional
Bifurcation
9.2.1.5.1. North
America
9.2.1.5.1.1. Market
Estimation, 2015 – 2018
9.2.1.5.1.2. Market
Forecast, 2019 – 2027
9.2.1.5.2. Europe
9.2.1.5.2.1. Market
Estimation, 2015 – 2018
9.2.1.5.2.2. Market
Forecast, 2019 – 2027
9.2.1.5.3. Asia
Pacific
9.2.1.5.3.1. Market
Estimation, 2015 – 2018
9.2.1.5.3.2. Market
Forecast, 2019 – 2027
9.2.1.5.4. Middle
East and Africa
9.2.1.5.4.1. Market
Estimation, 2015 – 2018
9.2.1.5.4.2. Market
Forecast, 2019 – 2027
9.2.1.5.5. Latin
America
9.2.1.5.5.1. Market
Estimation, 2015 – 2018
9.2.1.5.5.2. Market
Forecast, 2019 – 2027
9.2.2. Epilepsy
9.2.2.1. Definition
9.2.2.2. Market
Estimation and Penetration, 2015 – 2018
9.2.2.3. Market
Forecast, 2019 – 2027
9.2.2.4. Compound
Annual Growth Rate (CAGR)
9.2.2.5. Regional
Bifurcation
9.2.2.5.1. North
America
9.2.2.5.1.1. Market
Estimation, 2015 – 2018
9.2.2.5.1.2. Market
Forecast, 2019 – 2027
9.2.2.5.2. Europe
9.2.2.5.2.1. Market
Estimation, 2015 – 2018
9.2.2.5.2.2. Market
Forecast, 2019 – 2027
9.2.2.5.3. Asia
Pacific
9.2.2.5.3.1. Market
Estimation, 2015 – 2018
9.2.2.5.3.2. Market
Forecast, 2019 – 2027
9.2.2.5.4. Middle
East and Africa
9.2.2.5.4.1. Market
Estimation, 2015 – 2018
9.2.2.5.4.2. Market
Forecast, 2019 – 2027
9.2.2.5.5. Latin
America
9.2.2.5.5.1. Market
Estimation, 2015 – 2018
9.2.2.5.5.2. Market
Forecast, 2019 – 2027
9.3. Key
Segment for Channeling Investments
9.3.1. By
Application
10. North America Transcranial Magnetic Stimulator Market
Analysis and Forecasts, 2019 - 2027
10.1. Overview
10.1.1. North
America Transcranial Magnetic Stimulator Market Revenue (US$ Mn)
10.2. North
America Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts,
By Type
10.2.1. Deep
TMS
10.2.2. Repetitive
TMS
10.2.3. Others
10.3. North
America Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts,
By Application
10.3.1. Depression
10.3.2. Epilepsy
10.4. North
America Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts,
By Country
10.4.1. U.S
10.4.1.1. U.S
Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Type
10.4.1.1.1. Deep
TMS
10.4.1.1.2. Repetitive
TMS
10.4.1.1.3. Others
10.4.1.2. U.S
Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By
Application
10.4.1.2.1. Depression
10.4.1.2.2. Epilepsy
10.4.2. Canada
10.4.2.1. Canada
Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Type
10.4.2.1.1. Deep
TMS
10.4.2.1.2. Repetitive
TMS
10.4.2.1.3. Others
10.4.2.2. Canada
Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By
Application
10.4.2.2.1. Depression
10.4.2.2.2. Epilepsy
10.4.3. Mexico
10.4.3.1. Mexico
Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Type
10.4.3.1.1. Deep
TMS
10.4.3.1.2. Repetitive
TMS
10.4.3.1.3. Others
10.4.3.2. Mexico
Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By
Application
10.4.3.2.1. Depression
10.4.3.2.2. Epilepsy
10.4.4. Rest of
North America
10.4.4.1. Rest
of North America Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and
Forecasts, By Type
10.4.4.1.1. Deep
TMS
10.4.4.1.2. Repetitive
TMS
10.4.4.1.3. Others
10.4.4.2. Rest
of North America Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and
Forecasts, By Application
10.4.4.2.1. Depression
10.4.4.2.2. Epilepsy
10.5. Key
Segment for Channeling Investments
10.5.1. By
Country
10.5.2. By Type
10.5.3. By
Application
11. Europe Transcranial Magnetic Stimulator Market Analysis and
Forecasts, 2019 - 2027
11.1. Overview
11.1.1. Europe
Transcranial Magnetic Stimulator Market Revenue (US$ Mn)
11.2. Europe
Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Type
11.2.1. Deep
TMS
11.2.2. Repetitive
TMS
11.2.3. Others
11.3. Europe
Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By
Application
11.3.1. Depression
11.3.2. Epilepsy
11.4. Europe
Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By
Country
11.4.1. France
11.4.1.1. France
Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Type
11.4.1.1.1. Deep
TMS
11.4.1.1.2. Repetitive
TMS
11.4.1.1.3. Others
11.4.1.2. France
Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By
Application
11.4.1.2.1. Depression
11.4.1.2.2. Epilepsy
11.4.2. The UK
11.4.2.1. The
UK Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By
Type
11.4.2.1.1. Deep
TMS
11.4.2.1.2. Repetitive
TMS
11.4.2.1.3. Others
11.4.2.2. The
UK Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By
Application
11.4.2.2.1. Depression
11.4.2.2.2. Epilepsy
11.4.3. Spain
11.4.3.1. Spain
Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Type
11.4.3.1.1. Deep
TMS
11.4.3.1.2. Repetitive
TMS
11.4.3.1.3. Others
11.4.3.2. Spain
Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By
Application
11.4.3.2.1. Depression
11.4.3.2.2. Epilepsy
11.4.4. Germany
11.4.4.1. Germany
Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Type
11.4.4.1.1. Deep
TMS
11.4.4.1.2. Repetitive
TMS
11.4.4.1.3. Others
11.4.4.2. Germany
Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By
Application
11.4.4.2.1. Depression
11.4.4.2.2. Epilepsy
11.4.5. Italy
11.4.5.1. Italy
Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Type
11.4.5.1.1. Deep
TMS
11.4.5.1.2. Repetitive
TMS
11.4.5.1.3. Others
11.4.5.2. Italy
Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By
Application
11.4.5.2.1. Depression
11.4.5.2.2. Epilepsy
11.4.6. Nordic
Countries
11.4.6.1. Nordic
Countries Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and
Forecasts, By Type
11.4.6.1.1. Deep
TMS
11.4.6.1.2. Repetitive
TMS
11.4.6.1.3. Others
11.4.6.2. Nordic
Countries Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and
Forecasts, By Application
11.4.6.2.1. Depression
11.4.6.2.2. Epilepsy
11.4.6.3. Nordic
Countries Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and
Forecasts, By Country
11.4.6.3.1. Denmark
11.4.6.3.2. Finland
11.4.6.3.3. Iceland
11.4.6.3.4. Sweden
11.4.6.3.5. Norway
11.4.7. Benelux
Union
11.4.7.1. Benelux
Union Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts,
By Type
11.4.7.1.1. Deep
TMS
11.4.7.1.2. Repetitive
TMS
11.4.7.1.3. Others
11.4.7.2. Benelux
Union Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts,
By Application
11.4.7.2.1. Depression
11.4.7.2.2. Epilepsy
11.4.7.3. Benelux
Union Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts,
By Country
11.4.7.3.1. Belgium
11.4.7.3.2. The
Netherlands
11.4.7.3.3. Luxembourg
11.4.8. Rest of
Europe
11.4.8.1. Rest
of Europe Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and
Forecasts, By Type
11.4.8.1.1. Deep
TMS
11.4.8.1.2. Repetitive
TMS
11.4.8.1.3. Others
11.4.8.2. Rest
of Europe Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and
Forecasts, By Application
11.4.8.2.1. Depression
11.4.8.2.2. Epilepsy
11.5. Key
Segment for Channeling Investments
11.5.1. By
Country
11.5.2. By Type
11.5.3. By
Application
12. Asia Pacific Transcranial Magnetic Stimulator Market Analysis
and Forecasts, 2019 - 2027
12.1. Overview
12.1.1. Asia
Pacific Transcranial Magnetic Stimulator Market Revenue (US$ Mn)
12.2. Asia
Pacific Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts,
By Type
12.2.1. Deep
TMS
12.2.2. Repetitive
TMS
12.2.3. Others
12.3. Asia
Pacific Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts,
By Application
12.3.1. Depression
12.3.2. Epilepsy
12.4. Asia
Pacific Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts,
By Country
12.4.1. China
12.4.1.1. China
Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Type
12.4.1.1.1. Deep
TMS
12.4.1.1.2. Repetitive
TMS
12.4.1.1.3. Others
12.4.1.2. China
Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By
Application
12.4.1.2.1. Depression
12.4.1.2.2. Epilepsy
12.4.2. Japan
12.4.2.1. Japan
Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Type
12.4.2.1.1. Deep
TMS
12.4.2.1.2. Repetitive
TMS
12.4.2.1.3. Others
12.4.2.2. Japan
Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By
Application
12.4.2.2.1. Depression
12.4.2.2.2. Epilepsy
12.4.3. India
12.4.3.1. India
Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Type
12.4.3.1.1. Deep
TMS
12.4.3.1.2. Repetitive
TMS
12.4.3.1.3. Others
12.4.3.2. India
Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By
Application
12.4.3.2.1. Depression
12.4.3.2.2. Epilepsy
12.4.4. New
Zealand
12.4.4.1. New
Zealand Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts,
By Type
12.4.4.1.1. Deep
TMS
12.4.4.1.2. Repetitive
TMS
12.4.4.1.3. Others
12.4.4.2. New
Zealand Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts,
By Application
12.4.4.2.1. Depression
12.4.4.2.2. Epilepsy
12.4.5. Australia
12.4.5.1. Australia
Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Type
12.4.5.1.1. Deep
TMS
12.4.5.1.2. Repetitive
TMS
12.4.5.1.3. Others
12.4.5.2. Australia
Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By
Application
12.4.5.2.1. Depression
12.4.5.2.2. Epilepsy
12.4.6. South
Korea
12.4.6.1. South
Korea Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts,
By Type
12.4.6.1.1. Deep
TMS
12.4.6.1.2. Repetitive
TMS
12.4.6.1.3. Others
12.4.6.2. South
Korea Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts,
By Application
12.4.6.2.1. Depression
12.4.6.2.2. Epilepsy
12.4.7. Southeast
Asia
12.4.7.1. Southeast
Asia Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By
Type
12.4.7.1.1. Deep
TMS
12.4.7.1.2. Repetitive
TMS
12.4.7.1.3. Others
12.4.7.2. Southeast
Asia Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By
Application
12.4.7.2.1. Depression
12.4.7.2.2. Epilepsy
12.4.7.3. Southeast
Asia Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By
Country
12.4.7.3.1. Indonesia
12.4.7.3.2. Thailand
12.4.7.3.3. Malaysia
12.4.7.3.4. Singapore
12.4.7.3.5. Rest
of Southeast Asia
12.4.8. Rest of
Asia Pacific
12.4.8.1. Rest
of Asia Pacific Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and
Forecasts, By Type
12.4.8.1.1. Deep
TMS
12.4.8.1.2. Repetitive
TMS
12.4.8.1.3. Others
12.4.8.2. Rest
of Asia Pacific Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and
Forecasts, By Application
12.4.8.2.1. Depression
12.4.8.2.2. Epilepsy
12.5. Key
Segment for Channeling Investments
12.5.1. By
Country
12.5.2. By Type
12.5.3. By
Application
13. Middle East and Africa Transcranial Magnetic Stimulator
Market Analysis and Forecasts, 2019 - 2027
13.1. Overview
13.1.1. Middle
East and Africa Transcranial Magnetic Stimulator Market Revenue (US$ Mn)
13.2. Middle
East and Africa Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and
Forecasts, By Type
13.2.1. Deep
TMS
13.2.2. Repetitive
TMS
13.2.3. Others
13.3. Middle
East and Africa Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts,
By Application
13.3.1. Depression
13.3.2. Epilepsy
13.4. Middle
East and Africa Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and
Forecasts, By Country
13.4.1. Saudi
Arabia
13.4.1.1. Saudi
Arabia Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts,
By Type
13.4.1.1.1. Deep
TMS
13.4.1.1.2. Repetitive
TMS
13.4.1.1.3. Others
13.4.1.2. Saudi
Arabia Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts,
By Application
13.4.1.2.1. Depression
13.4.1.2.2. Epilepsy
13.4.2. UAE
13.4.2.1. UAE
Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Type
13.4.2.1.1. Deep
TMS
13.4.2.1.2. Repetitive
TMS
13.4.2.1.3. Others
13.4.2.2. UAE
Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By
Application
13.4.2.2.1. Depression
13.4.2.2.2. Epilepsy
13.4.3. Egypt
13.4.3.1. Egypt
Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Type
13.4.3.1.1. Deep
TMS
13.4.3.1.2. Repetitive
TMS
13.4.3.1.3. Others
13.4.3.2. Egypt
Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By
Application
13.4.3.2.1. Depression
13.4.3.2.2. Epilepsy
13.4.4. Kuwait
13.4.4.1. Kuwait
Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Type
13.4.4.1.1. Deep
TMS
13.4.4.1.2. Repetitive
TMS
13.4.4.1.3. Others
13.4.4.2. Kuwait
Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By
Application
13.4.4.2.1. Depression
13.4.4.2.2. Epilepsy
13.4.5. South
Africa
13.4.5.1. South
Africa Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts,
By Type
13.4.5.1.1. Deep
TMS
13.4.5.1.2. Repetitive
TMS
13.4.5.1.3. Others
13.4.5.2. South
Africa Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts,
By Application
13.4.5.2.1. Depression
13.4.5.2.2. Epilepsy
13.4.6. Rest of
Middle East & Africa
13.4.6.1. Rest
of Middle East & Africa Transcranial Magnetic Stimulator Market Revenue
(US$ Mn) and Forecasts, By Type
13.4.6.1.1. Deep
TMS
13.4.6.1.2. Repetitive
TMS
13.4.6.1.3. Others
13.4.6.2. Rest
of Middle East & Africa Transcranial Magnetic Stimulator Market Revenue
(US$ Mn) and Forecasts, By Application
13.4.6.2.1. Depression
13.4.6.2.2. Epilepsy
13.5. Key
Segment for Channeling Investments
13.5.1. By
Country
13.5.2. By Type
13.5.3. By
Application
14. Latin America Transcranial Magnetic Stimulator Market
Analysis and Forecasts, 2019 - 2027
14.1. Overview
14.1.1. Latin
America Transcranial Magnetic Stimulator Market Revenue (US$ Mn)
14.2. Latin
America Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts,
By Type
14.2.1. Deep TMS
14.2.2. Repetitive
TMS
14.2.3. Others
14.3. Latin
America Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts,
By Application
14.3.1. Depression
14.3.2. Epilepsy
14.4. Latin
America Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts,
By Country
14.4.1. Brazil
14.4.1.1. Brazil
Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Type
14.4.1.1.1. Deep
TMS
14.4.1.1.2. Repetitive
TMS
14.4.1.1.3. Others
14.4.1.2. Brazil
Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By
Application
14.4.1.2.1. Depression
14.4.1.2.2. Epilepsy
14.4.2. Argentina
14.4.2.1. Argentina
Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Type
14.4.2.1.1. Deep
TMS
14.4.2.1.2. Repetitive
TMS
14.4.2.1.3. Others
14.4.2.2. Argentina
Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By
Application
14.4.2.2.1. Depression
14.4.2.2.2. Epilepsy
14.4.3. Rest of
Latin America
14.4.3.1. Rest
of Latin America Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and
Forecasts, By Type
14.4.3.1.1. Deep
TMS
14.4.3.1.2. Repetitive
TMS
14.4.3.1.3. Others
14.4.3.2. Rest
of Latin America Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and
Forecasts, By Application
14.4.3.2.1. Depression
14.4.3.2.2. Epilepsy
14.5. Key
Segment for Channeling Investments
14.5.1. By
Country
14.5.2. By Type
14.5.3. By
Application
15. Competitive Benchmarking
15.1. Market
Share Analysis, 2018
15.2. Global
Presence and Growth Strategies
15.2.1. Mergers
and Acquisitions
15.2.2. Product
Launches
15.2.3. Investments
Trends
15.2.4. R&D
Initiatives
16. Player Profiles
16.1. Nexstim
Plc
16.1.1. Company
Details
16.1.2. Company
Overview
16.1.3. Product
Offerings
16.1.4. Key
Developments
16.1.5. Financial
Analysis
16.1.6. SWOT
Analysis
16.1.7. Business
Strategies
16.2. Magstim
16.2.1. Company
Details
16.2.2. Company
Overview
16.2.3. Product
Offerings
16.2.4. Key
Developments
16.2.5. Financial
Analysis
16.2.6. SWOT
Analysis
16.2.7. Business
Strategies
16.3. Neuronetics,
Inc
16.3.1. Company
Details
16.3.2. Company
Overview
16.3.3. Product
Offerings
16.3.4. Key
Developments
16.3.5. Financial
Analysis
16.3.6. SWOT
Analysis
16.3.7. Business
Strategies
16.4. TMS
Neurosolutions
16.4.1. Company
Details
16.4.2. Company
Overview
16.4.3. Product
Offerings
16.4.4. Key
Developments
16.4.5. Financial
Analysis
16.4.6. SWOT
Analysis
16.4.7. Business
Strategies
16.5. Mag
Venture
16.5.1. Company
Details
16.5.2. Company
Overview
16.5.3. Product
Offerings
16.5.4. Key
Developments
16.5.5. Financial
Analysis
16.5.6. SWOT
Analysis
16.5.7. Business
Strategies
16.6. eNeura
Inc
16.6.1. Company
Details
16.6.2. Company
Overview
16.6.3. Product
Offerings
16.6.4. Key
Developments
16.6.5. Financial
Analysis
16.6.6. SWOT
Analysis
16.6.7. Business Strategies
16.7. Other
Market Participants
17. Key Findings
Note: This ToC is tentative
and can be changed according to the research study conducted during the course
of report completion.
**Exclusive for Multi-User and Enterprise
User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.